524663
BIBCL
Invest Now
Bharat Immunological & Biologicals Corporation Share Price
₹24.10 +0.2 (0.84%)
02 Dec, 2024 14:34
Start SIP in BIBCL
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month -3.72%
- Over 3 Month -18.28%
- Over 6 Month -18.11%
- Over 1 Year -9.67%
Smart Investing Starts Here Start SIP with Bharat Immunological & Biologicals Corporation for Steady Growth!
Bharat Immunological & Biologicals Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Technicals
EMA & SMA
Current Price
₹24.10
+
0.2
(0.84%)
- Bullish Moving Average 5
- Bearish Moving Average 11
- 20 Day
- ₹24.32
- 50 Day
- ₹25.62
- 100 Day
- ₹27.04
- 200 Day
- ₹28.02
Resistance and Support
24.12
- R3 25.56
- R2 25.15
- R1 24.53
- S1 23.50
- S2 23.09
- S3 22.47
Bharat Immunological & Biologicals Corporation Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-08-16 | General Purpose. | |
2024-03-08 | Others | General Purpose |
2023-10-31 | Quarterly Results | |
2023-04-24 | Audited Results | |
2023-02-09 | Quarterly Results |
Bharat Immunological & Biologicals Corporation F&O
About Bharat Immunological & Biologicals Corporation
- NSE Symbol
- BIBCL
- BSE Symbol
- 524663
- ISIN
- INE994B01014
Similar Stocks to Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biologicals Corporation FAQs
Bharat Immunological & Biologicals Corporation share price is ₹24 As on 02 December, 2024 | 14:20
The Market Cap of Bharat Immunological & Biologicals Corporation is ₹104.1 Cr As on 02 December, 2024 | 14:20
The P/E ratio of Bharat Immunological & Biologicals Corporation is -5.6 As on 02 December, 2024 | 14:20
The PB ratio of Bharat Immunological & Biologicals Corporation is 1.2 As on 02 December, 2024 | 14:20
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.